Oliver McCammon
Stock Analyst at LifeSci Capital
(4.61)
# 948
Out of 5,133 analysts
89
Total ratings
28.4%
Success rate
31.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Oliver McCammon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTH Faeth Therapeutics | Initiated Coverage: Buy | $40 | $10.03 | +298.80% | 1 | Oct 15, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | n/a | $9.37 | - | 17 | Oct 2, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $38 | $3.39 | +1,020.94% | 11 | Sep 14, 2026 | |
| INBX Inhibrx Biosciences | Reiterated: Buy | $230 | $83.30 | +176.11% | 5 | Sep 8, 2026 | |
| CADL Candel Therapeutics | Reiterated: Buy | $16 | $6.20 | +158.06% | 6 | Aug 14, 2026 | |
| CELC Celcuity | Reiterated: Buy | $165 | $64.37 | +156.33% | 15 | Aug 14, 2026 | |
| AURA Aura Biosciences | Reiterated: Buy | $23 | $7.11 | +223.49% | 10 | Aug 12, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $15 | $0.9431 | +1,490.50% | 11 | Aug 11, 2026 | |
| JANX Janux Therapeutics | Reiterated: Buy | $60 | $11.37 | +427.70% | 13 | Aug 7, 2026 |
Faeth Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $10.03
Upside: +298.80%
Monte Rosa Therapeutics
Oct 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.37
Upside: -
Corbus Pharmaceuticals Holdings
Sep 14, 2026
Reiterated: Buy
Price Target: $38
Current: $3.39
Upside: +1,020.94%
Inhibrx Biosciences
Sep 8, 2026
Reiterated: Buy
Price Target: $230
Current: $83.30
Upside: +176.11%
Candel Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $16
Current: $6.20
Upside: +158.06%
Celcuity
Aug 14, 2026
Reiterated: Buy
Price Target: $165
Current: $64.37
Upside: +156.33%
Aura Biosciences
Aug 12, 2026
Reiterated: Buy
Price Target: $23
Current: $7.11
Upside: +223.49%
Perspective Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $15
Current: $0.9431
Upside: +1,490.50%
Janux Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $60
Current: $11.37
Upside: +427.70%